Internists issue recommendations for preventing and treating substance use disorders

March 27, 2017, American College of Physicians

The American College of Physicians (ACP) today released a paper with a comprehensive set of public policy recommendations for the prevention and treatment of substance use disorders involving illicit and prescription drugs. The paper is published in Annals of Internal Medicine.

"Drug overdose deaths, particularly from opioids such as and heroin, is a rising epidemic," said Nitin S. Damle, MD, MS, MACP, president, ACP. "Substance use disorders are treatable chronic medical conditions, like diabetes and hypertension, that should be addressed through expansion of evidence-based public and individual health initiatives to prevent, treat, and promote recovery."

ACP says that substance use disorders pose a heavy societal burden, endangering individual and family health and well-being, tearing through communities and sapping resources from the health care system. These disorders are common in the general population and at even higher rates among those who are incarcerated.

Access to care for substance use disorders is limited. In 2014, 22.5 million people in the U.S. needed for an or alcohol use problems but only 18 percent received any treatment, far below treatment receipt rates for those with hypertension (77 percent), diabetes (73 percent), or major depression (71 percent).

To combat the epidemic of , ACP recommends that physicians become familiar with and follow as appropriate clinical guidelines related to pain management and controlled such as prescription opioids as well as non-opioid drugs and non-drug interventions; the expansion of access to naloxone to opioid users, law enforcement, and emergency medical personnel; the expansion of access to medication-assisted treatment of opioid use disorders; improved training in the treatment of substance use disorders including buprenorphine-based treatment; and the establishment of a national Prescription Drug Monitoring Program and improvement of existing monitoring programs.

"ACP strongly urges prescribers to check Prescription Drug Monitoring Programs in their own and neighboring states as permitted prior to writing prescriptions for medications containing controlled substances," Dr. Damle said.

Additional recommendations from ACP include emphasizing prevention and treatment of substance use disorders through public and individual health interventions rather than excessive reliance on criminalization and incarceration; requiring health insurance to cover including the evidence-based treatment of substance use disorders and abide parity rules; embedding training in the treatment of substance use disorders throughout the continuum of medical education; expanding the workforce of professionals qualified to treat substance use disorders; and studying the effectiveness of to combat substance use disorders and associated health problems.

"Physicians can help guide their patients towards recovery by becoming educated about and proper prescribing practices, consulting prescription drug monitoring systems to reduce opioid misuse, and assisting patients in their treatment," said Dr. Damle.

Although a number of states have legalized or decriminalized use and sale of medical and/or recreational marijuana, its use and possession remains illegal under federal law and in many states. Therefore, ACP included it as an illicit drug.

ACP recognizes that alcohol and tobacco use are serious public problems. Policies to address such issues are outside the scope of the paper.

Methods

The position paper was drafted by ACP's Health and Public Policy Committee. The authors reviewed available studies, reports, and surveys on the prevention and treatment of substance use disorder from PubMed, Google Scholar, relevant news articles, policy documents, websites, and other sources. The authors largely excluded sources that were more than ten years old, with the exception of a number of federal government reports that were included for background purposes.

ACP's recommendations are based on reviewed literature and input from the ACP's Board of Governors, Board of Regents, Council of Early Career Physicians, Council of Resident/Fellow Members, Council of Student Members, and Council of Subspecialty Societies and nonmember experts in the field.

Explore further: Giving up cigarettes linked with recovery from illicit substance use disorders

More information: Annals of Internal Medicine, annals.org/aim/article/doi/10.7326/M16-2953

Related Stories

Giving up cigarettes linked with recovery from illicit substance use disorders

March 7, 2017
Smokers in recovery from illicit drug use disorders are at greater risk of relapsing three years later compared with those who do not smoke cigarettes. Results of the study by researchers at Columbia University's Mailman ...

Drug and alcohol problems linked to increased veteran suicide risk, especially in women

March 16, 2017
Veterans who have drug or alcohol problems are more than twice as likely to die by suicide as their comrades, a new study finds. And women veterans with substance use disorders have an even higher rate of suicide—more than ...

Medicaid expansion linked to increased prescribing of buprenorphine for opioid use disorder treatment

March 16, 2017
States where Medicaid coverage was expanded under the Affordable Care Act have had a significant increase in prescribing of buprenorphine—a medication that plays an important role in addressing the opioid epidemic, reports ...

Many patients receive prescription opioids during treatment for opioid addiction

February 23, 2017
More than two in five people receiving buprenorphine, a drug commonly used to treat opioid addiction, are also given prescriptions for other opioid painkillers - and two-thirds are prescribed opioids after their treatment ...

Overhaul of US drug policy is long overdue, expert says

March 9, 2017
A new report from the Office of the Surgeon General, "Facing Addiction in America," suggests that an overhaul of U.S. drug policy is long overdue, according to a new issue brief from a drug policy expert at Rice University's ...

Psychiatric conditions linked to increased risk of long-term opioid use

December 29, 2016
A wide range of pre-existing psychiatric and behavioral conditions and the use of psychoactive drugs could be important risk factors leading to long-term use of opioid pain medications, reports a study in Pain, the official ...

Recommended for you

Cannabinoids are easier on the brain than booze, study finds

February 9, 2018
Marijuana may not be as damaging to the brain as previously thought, according to new research from the University of Colorado Boulder and the CU Change Lab.

Marijuana use may not aid patients in opioid addiction treatment

December 4, 2017
Many patients who are being treated for opioid addiction in a medication-assisted treatment clinic use marijuana to help manage their pain and mood symptoms.

For opiate addiction, study finds drug-assisted treatment is more effective than detox

November 23, 2017
Say you're a publicly insured Californian with an addiction to heroin, fentanyl or prescription narcotics, and you want to quit.

Study finds medical cannabis is effective at reducing opioid addiction

November 17, 2017
A new study conducted by researchers at The University of New Mexico, involving medical cannabis and prescription opioid use among chronic pain patients, found a distinct connection between having the legal ability to use ...

Insomnia linked to alcohol-use frequency among early adolescents, says new psychology study

November 8, 2017
Insomnia is linked to frequency of alcohol use among early adolescents, according to new Rutgers University–Camden research.

Large declines seen in teen substance abuse, delinquency

October 25, 2017
More than a decade of data indicates teens have become far less likely to abuse alcohol, nicotine and illicit drugs, and they also are less likely to engage in delinquent behaviors, such as fighting and stealing, according ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (1) Mar 28, 2017
250mg of healthy adult male facial skin surface (mostly sebaceous) lipid pheromone alleviates opioid addiction (heroin, cocaine, and oxycodone have been tested anecdotally) with no withdrawal symptoms. As the skin surface pheromone emits an airborne pheromone which appears to cause stupidity, arrogance, suspicion, and jealousy, and given the potency of pheromones generally, measures to assure semiochemical sepsis must be taken, e.g. supplied air respirators for staff, sealed packaging for pheromone collected as well as activated charcoal dunnage, etc.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.